勘误：转移性乳腺癌患者局部区域手术治疗生存获益的个体化预测。
Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
作者信息
Zheng Yajuan, Zhong Guansheng, Yu Kun, Lei Kefeng, Yang Qiong
机构信息
Department of Breast and Thyroid Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
出版信息
Front Oncol. 2020 Apr 9;10:482. doi: 10.3389/fonc.2020.00482. eCollection 2020.
Abstract
[This corrects the article DOI: 10.3389/fonc.2020.00148.].
摘要
[本文更正了文章DOI：10.3389/fonc.2020.00148。]
相似文献
1
Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.勘误：转移性乳腺癌患者局部区域手术治疗生存获益的个体化预测。
Front Oncol. 2020 Apr 9;10:482. doi: 10.3389/fonc.2020.00482. eCollection 2020.
2
Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.转移性乳腺癌患者局部区域手术治疗生存获益的个体化预测
Front Oncol. 2020 Feb 18;10:148. doi: 10.3389/fonc.2020.00148. eCollection 2020.
3
Corrigendum: Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma.勘误：预测成神经管细胞瘤成年患者癌症特异性生存的预后列线图的开发与验证
Front Oncol. 2020 Oct 2;10:594049. doi: 10.3389/fonc.2020.594049. eCollection 2020.
4
Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer.为接受手术切除的初治IV期乳腺癌患者术后放疗获益开发个体化预测计算器
Cancers (Basel). 2020 Jul 29;12(8):2103. doi: 10.3390/cancers12082103.
5
Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis.勘误：肺黏液表皮样癌患者的临床特征与预后：一项基于监测、流行病学和最终结果（SEER）数据库的分析
Front Oncol. 2024 Sep 13;14:1486678. doi: 10.3389/fonc.2024.1486678. eCollection 2024.
6
Nomogram predicts survival benefit from preoperative radiotherapy for non-metastatic breast cancer: A SEER-based study.列线图预测非转移性乳腺癌术前放疗的生存获益：一项基于监测、流行病学和最终结果（SEER）数据库的研究
Oncotarget. 2017 Jul 25;8(30):49861-49868. doi: 10.18632/oncotarget.17991.
7
Corrigendum: Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study.勘误：保乳治疗与乳房切除术治疗早期乳腺浸润性微乳头状癌患者的生存结果：一项基于监测、流行病学和最终结果（SEER）数据库的人群研究。
Front Oncol. 2022 Apr 13;12:890018. doi: 10.3389/fonc.2022.890018. eCollection 2022.
8
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.勘误：吡咯替尼治疗HER2阳性转移性乳腺癌患者的有效性、安全性及生物标志物与无进展生存期的关系：一项真实世界、多中心分析
Front Oncol. 2021 Mar 5;11:661128. doi: 10.3389/fonc.2021.661128. eCollection 2021.
9
Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.具有 1-3 个阳性腋窝淋巴结的乳腺癌患者术后放疗生存获益的个体化预测。
Oncologist. 2019 Dec;24(12):e1286-e1293. doi: 10.1634/theoncologist.2019-0124. Epub 2019 Jul 17.
10
Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.勘误：基于套索算法得出的预后模型预测50岁以上晚期胰腺导管腺癌患者的癌症特异性生存率：一项基于监测、流行病学和最终结果（SEER）数据库研究的回顾性研究
Front Oncol. 2024 Feb 7;14:1370998. doi: 10.3389/fonc.2024.1370998. eCollection 2024.
Zotero 插件